References

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

10.1161/01.cir.98.8.731 · 1998 · External reference

C-reactive protein and the risk of developing hypertension

10.1001/jama.290.22.2945 · 2003 · External reference

Inflammation and the long-term incidence of hypertension in women

10.1093/eurjpc/zwag426 · External reference

Sex differences in arterial hypertension

10.1093/eurheartj/ehac470 · 2022 · External reference

Stage 1 hypertension, sex, and acute coronary syndromes during midlife: the Hordaland Health Study

10.1093/eurjpc/zwab068 · 2022 · External reference

Effects of interleukin-1β inhibition on blood pressure, incident hypertension, and residual inflammatory risk: a secondary analysis of CANTOS

10.1161/hypertensionaha.119.13642 · 2020 · External reference

Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK

10.1016/s0140-6736(22)01349-6 · 2022 · External reference

Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial

10.1136/ard.2009.124180 · 2010 · External reference

Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)

10.1016/j.amjcard.2010.03.018 · 2010 · External reference

Inflammation, sex, blood pressure changes and hypertension in midlife: the Hordaland Health Study

10.1038/s41371-022-00772-z · 2023 · External reference